MBA
AVNS icon

McQueen Ball & Associates’s Avanos Medical AVNS Stock Holding History

McQueen Ball & Associates’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,906
Closed -$268K – 114
2018
Q3 		$268K Hold
3,906
– – 0.15% 92
2018
Q2 		$224K Buy
+3,906
New +$206K 0.14% 100

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

McQueen Ball & Associates's AVNS Position: Q4 2018 in Review

McQueen Ball & Associates sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 3,906 shares — an estimated $268K sold.

McQueen Ball & Associates first reported a position in AVNS in Q2 2018 and held it in 2 quarters. The position peaked at $268K in Q3 2018. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

  • McQueen Ball & Associates reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
  • McQueen Ball & Associates sold 3,906 Avanos Medical shares in Q4 2018, an estimated $268K.
  • McQueen Ball & Associates first reported a position in Avanos Medical in Q2 2018 and held it in 2 quarters.
  • McQueen Ball & Associates's Avanos Medical position peaked at $268K in Q3 2018.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on McQueen Ball & Associates's 13F filing for Q4 2018, filed 3 Jan 2019.